BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2014 11:44:00 AM | Browse: 1184 | Download: 1135
 |
Received |
|
2013-12-29 15:30 |
 |
Peer-Review Started |
|
2013-12-29 20:11 |
 |
To Make the First Decision |
|
2014-01-08 14:08 |
 |
Return for Revision |
|
2014-01-20 22:05 |
 |
Revised |
|
2014-01-23 15:28 |
 |
Second Decision |
|
2014-03-12 18:34 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-03-12 18:41 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-05-07 14:46 |
 |
Publish the Manuscript Online |
|
2014-05-12 18:06 |
Category |
Oncology |
Manuscript Type |
Topic Highlights |
Article Title |
Resection of the primary tumor in stage Ⅳ breast cancer
|
Manuscript Source |
Invited Manuscript |
All Author List |
Tadahiko Shien and Hiroyoshi Doihara |
Funding Agency and Grant Number |
|
Corresponding Author |
Tadahiko Shien, MD, PhD, Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, 7008558 Okayama, Japan. tshien@md.okayama-u.ac.jp |
Key Words |
Breast cancer; Metastasis; Surgery; Survival; Stage IV; Clinical trial |
Core Tip |
Resection of a primary tumor of stage IV breast cancer was considered to be “effective only at alleviating chest symptoms and providing local control” in spite of the advances of imaging examination and medication for breast cancer. Recently, many retrospective studies have reported the survival benefit of surgery for breast cancer patients with metastases and some clinical trials which confirm the surgical prognostic benefit for them have started to enrol patients. We need to evaluate the treatment strategy, including primary resection for stage IV breast cancer particularly, and find new evidence by prospective analysis. |
Publish Date |
2014-05-12 18:06 |
Citation |
Shien T, Doihara H. Resection of the primary tumor in stage Ⅳ breast cancer. World J Clin Oncol 2014; 5(2): 82-85 |
URL |
http://www.wjgnet.com/2218-4333/full/v5/i2/82.htm |
DOI |
http://dx.doi.org/10.5306/wjco.v5.i2.82 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345